Mortality rates from cryptogenic fibrosing alveolitis in seven countries

Thorax

Volumn 51, Issue 7, 1996, Pages 711-716

  Hubbard, Richard ^a   Johnston, Ian ^b   Coultas, David B ^c   Britton, John ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Cryptogenic fibrosing alveolitis; Epidemiology; Mortality; Post inflammatory fibrosis

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; CANADA; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FIBROSING ALVEOLITIS; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW ZEALAND; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0029899775     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.7.711     Document Type: Article

References (21)

1. Hamman L, Rich AR. Fulminating diffuse interstitial fibrosis of the lungs. Trans Am Clin Climatol Assoc 1935;51:154-63.
2. World Health Organisation. International Classification of Diseases 1975. 9th revision. 9th ed. Geneva: WHO, 1977.
3. Johnston I, Britton J, Kinnear W, Logan R. Rising mortality from cryptogenic fibrosing alveolitis. BMJ 1990;301: 1017-21.
4. Office of Population Censuses and Surveys. Mortality statistics 1979-92. London: HMSO, 1980-93 (Series DH2).
5. Anonymous. EGRET reference manual. Seattle: Statistics and Epidemiology Research Corporation and Cytel Software Corporation, 1990.
6. Office of Population Censuses and Surveys. Mortality statistics 1984. London: HMSO, 1985 (Series DH2).
7. Scott J, Johnston I, Britton J. What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. BMJ 1990;301:1015-7.
8. Coultas DB, Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994;150:967-72.
9. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: response to cortieosteroid treatment and its effect on survival. Thorax 1980;35:593-9.
10. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980;35:171-80.
11. Carrington CB, Gaensler EA, Coutu RE, Fitzgerald MX, Gupta RG. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978;298:801-8.
12. Wright PH, Heard BE, Steel SJ, Turner-Warwick M. Cryptogenic fibrosing alveolitis: assessment by graded trephine lung biopsy histology compared with clinical, radiographic and physiological features. Br J Dis Chest 1981;75:61-70.
13. Wells AU, Cullinan P, Hansell DM, Rubens MB, Black CM, Newman-Taylor AJ, et al. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1994;149:1583-90.
14. Agusti C, Xaubet A, Augusti AGN, Roca J, Ramirez. J, Rodriguez-Roisin R. Clinical and functional assessment of patients with idiopathic pulmonary fibrosis: results of a three year follow up. Eur Respir J 1994;7:643-50.
15. Iwai K, Mori T, Yamada N, Yamuguchi M, Hosoda Y. Idiopathic pulmonary fibrosis: epidemiological approaches to occupational exposure. Am J Respir Crit Care Med 1994; 150:670-5.
16. Nemery B, Nagels J, Verbeken E, Dinsdale D, Demedts M. Rapidly fatal progression of cobalt lung in a diamond polisher. Am Rev Respir Dis 1990;141:1373-8.
17. Vallyathan V, Bergeron WN, Robichaux PA, Craighead JE. Pulmonary fibrosis in an aluminium arc welder. Chest 1982;81:372-4.
18. De Vuyst P, Dumortier P, Rickaert F, Van De Weyer R, Lenclud C, Yernaukt J. Occupational lung fibrosis in an aluminium polisher. Eur J Respir Dis 1986;68:131-40.
19. Ramage JE, Jr., Roggli VL, Bell DY, Piantadosi CC. Interstitial lung disease and domestic wood burning. Am Rev Respir Dis 1988;137:1229-32.
20. Raghu G, Depaso WJ, Cain K, Hammar SP, Wetzel CE, Dreis DF, et al. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. Am Rev Respir Dis 1991;144:219-6.
21. Johnson MA, Kwan S, Snell NJ, Nunn AJ, Darbyshire JH, Turner-Warwick M. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax 1989;44:280-8.